Plasma neurofilament light chain in early Parkinson’s disease predicts motor complications: a prospective cohort study

Ningning Che, Jingxuan Huang, Shichan Wang, Qirui Jiang, Tianmi Yang, Yi Xiao, Ruwei Ou, Chunyu Li, Huifang Shang · 2026

Read Plasma neurofilament light chain in early Parkinson’s disease predicts motor complications: a prospective cohort study by Ningning Che, Jingxuan Huang, Shichan Wang, Qirui Jiang, Tianmi Yang, Yi Xiao, Ruwei Ou, Chunyu Li, Huifang Shang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13578695.txt.

Description

Ningning Che and colleagues asked whether a blood test can warn which early Parkinson's patients will develop motor complications. Levodopa, the main Parkinson's drug, often brings motor fluctuations and involuntary movements over time, eroding quality of life. Their prospective study followed 173 early-stage patients for up to seven years, measuring five blood markers at baseline, one year, and two years.

Motor fluctuations struck 41.6 percent of patients and dyskinesias 17.9 percent. Those who developed complications started with higher neurofilament light chain, GFAP, and amyloid-beta 40, but only neurofilament light chain predicted complications on its own after adjustment. Higher levodopa dose and worse anxiety and depression also predicted trouble. The authors propose the blood marker for early risk sorting.

Catalog record

CREATORNingning Che, Jingxuan Huang, Shichan Wang, Qirui Jiang, Tianmi Yang, Yi Xiao, Ruwei Ou, Chunyu Li, Huifang Shang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13578695

Browse the full library · About the Tower of Babel